GS0421: Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases
Case File Event Statements
8/28/2023 - a year ago
27 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILEDType:REM1
5/3/2023 - a year ago
26 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLYType:ASCK
7/21/2021 - 3 years ago
25 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA